ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+32.3%
5Y CAGR+26.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+32.3%/yr
vs +9.7%/yr prior
5Y CAGR
+26.4%/yr
Recent acceleration
Acceleration
+22.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $51.66M | +15.9% |
| 2024 | $44.58M | +30.0% |
| 2023 | $34.29M | +53.6% |
| 2022 | $22.32M | +96.3% |
| 2021 | $11.37M | -28.9% |
| 2020 | $16.00M | -19.2% |
| 2019 | $19.81M | +28.7% |
| 2018 | $15.39M | +69.7% |
| 2017 | $9.07M | +212.1% |
| 2016 | $2.91M | - |